Compare Revvity Inc (RVTY) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs State Street PDR S&P Retail ETF — how do they compare? Revvity Inc trades at $154.18 (market cap $16.98B), while State Street PDR S&P Retail ETF trades at $84.09 (market cap $389.66M). The key difference: Revvity Inc is far larger — about 43.6× State Street PDR S&P Retail ETF's market cap, and Revvity Inc pays a 0.18% dividend while State Street PDR S&P Retail ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and State Street PDR S&P Retail ETF for 45 Days on average.
| RVTY | XRT | |
|---|---|---|
Market Cap | $16.98B | $389.66M |
Volume | 1,456,900 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $157.36 | $92.35 |
52-Week Low | $82.26 | $77.28 |
Typical Hold Time | 12 Days | 45 Days |
Enterprise Value | $19.30B | — |
Dividend Yield | 0.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
XRT trades at $83.91, up 1.21% today, with a bullish technical signal but bearish moving averages. Key resistance is at $85, with support at $83. The ETF tracks the retail sector, which faces mixed signals from economic data and consumer sentiment. Recent retail sales showed a rebound in August after a July dip, highlighting sector volatility.
Outlook is cautious due to macroeconomic pressures like inflation and interest rates, which may weigh on consumer spending. Analyst sentiment is mixed, with some expecting underperformance. Risks include economic headwinds and competitive pressures, but the ETF offers diversified retail exposure for investors betting on holiday sales strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
